Announcements

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Cancer Drug Development”, which are listed below:

1. “New Promising Steroidal Aromatase Inhibitors with Multi-Target Action on Estrogen and Androgen Receptors for Breast Cancer Treatment”
by Cristina Amaral, Cristina F. Almeida, Maria João Valente, Carla L. Varela, Saul C. Costa, Fernanda M. F. Roleira, Elisiário Tavares-da-Silva, Anne Marie Vinggaard, Natércia Teixeira and Georgina Correia-da-Silva
Cancers 2025, 17(2), 165; https://doi.org/10.3390/cancers17020165
Available online: https://www.mdpi.com/2072-6694/17/2/165

2. “Real-World Evidence of Bevacizumab and Panitumumab Drug Resistance and Drug Ineffectiveness from EudraVigilance Database”
by Razvan Constantin Vonica, Claudiu Morgovan, Anca Butuca, Manuela Pumnea, Remus Calin Cipaian, Adina Frum, Carmen Maximiliana Dobrea, Andreea Loredana Vonica-Tincu, Aliteia-Maria Pacnejer, Florina Batar et al.
Cancers 2025, 17(4), 663; https://doi.org/10.3390/cancers17040663
Available online: https://www.mdpi.com/2072-6694/17/4/663

3. “Tumor-Agnostic Therapies in Practice: Challenges, Innovations, and Future Perspectives”
by Sulin Wu and Rajat Thawani
Cancers 2025, 17(5), 801; https://doi.org/10.3390/cancers17050801
Available online: https://www.mdpi.com/2072-6694/17/5/801

4. “ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer”
by Shuqing Zhao, Edward Agyare, Xueyou Zhu, Jose Trevino, Sherise Rogers, Enrique Velazquez-Villarreal, Jason Brant, Payam Eliahoo, Jonathan Barajas, Ba Xuan Hoang et al.
Cancers 2025, 17(5), 870; https://doi.org/10.3390/cancers17050870
Available online: https://www.mdpi.com/2072-6694/17/5/870

5. “Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting”
by Francesca Maria Orlandella, Rosaria Arcone, Neila Luciano, Giuliana Salvatore and Maria Letizia Motti
Cancers 2025, 17(8), 1273; https://doi.org/10.3390/cancers17081273
Available online: https://www.mdpi.com/2072-6694/17/8/1273

6. “Camptothein-Based Anti-Cancer Therapies and Strategies to Improve Their Therapeutic Index”
by Jue Gong, Wenqiu Zhang and Joseph P. Balthasar
Cancers 2025, 17(6), 1032; https://doi.org/10.3390/cancers17061032
Available online: https://www.mdpi.com/2072-6694/17/6/1032

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Cancer Metastasis”, which are listed below:

1. “Addressing Challenges in Targeted Therapy for Metastatic Colorectal Cancer”
by Maria El Hage, Zhaoran Su and Michael Linnebacher
Cancers 2025, 17(7), 1098; https://doi.org/10.3390/cancers17071098
Available online: https://www.mdpi.com/2072-6694/17/7/1098

2. “Progress in Drug Delivery Systems Based on Nanoparticles for Improved Glioblastoma Therapy: Addressing Challenges and Investigating Opportunities”
by Md Ataur Rahman, Maroua Jalouli, Mahesh Kumar Yadab and Mohammed Al-Zharani
Cancers 2025, 17(4), 701; https://doi.org/10.3390/cancers17040701
Available online: https://www.mdpi.com/2072-6694/17/4/701

3. “Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy”
by Hicham Wahnou, Riad El Kebbaj, Soufyane Hba, Zaynab Ouadghiri, Othman El Faqer, Aline Pinon, Bertrand Liagre, Youness Limami and Raphaël Emmanuel Duval
Cancers 2025, 17(7), 1232; https://doi.org/10.3390/cancers17071232
Available online: https://www.mdpi.com/2072-6694/17/7/1232

4. “GATA3-Driven ceRNA Network in Lung Adenocarcinoma Bone Metastasis Progression and Therapeutic Implications”
by Yun Liu, Shihui Shen, Xudong Wang, Hansen Chen, Wenjie Ren, Haifeng Wei, Kun Li and Lei Li
Cancers 2025, 17(3), 559; https://doi.org/10.3390/cancers17030559
Available online: https://www.mdpi.com/2072-6694/17/3/559

5. “Deciphering the Blood–Brain Barrier Paradox in Brain Metastasis Development and Therapy”
by Jens Jeshu Peters, Chubei Teng, Kang Peng and Xuejun Li
Cancers 2025, 17(2), 298; https://doi.org/10.3390/cancers17020298
Available online: https://www.mdpi.com/2072-6694/17/2/298

6. “Cancer-Associated Fibroblasts Genes and Transforming Growth Factor Beta Pathway in Gastric Cancer for Novel Therapeutic Strategy”
by Hiroyuki Minoura, Riku Okamoto, Naoki Hiki and Keishi Yamashita
Cancers 2025, 17(5), 795; https://doi.org/10.3390/cancers17050795
Available online: https://www.mdpi.com/2072-6694/17/5/795

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Cancer Epidemiology and Prevention”, which are listed below:

1. “Disparities in Cancer Screening Among the Foreign-Born Population in the United States: A Narrative Review”
by Andrew Rosowicz and Daniel Brock Hewitt
Cancers 2025, 17(4), 576; https://doi.org/10.3390/cancers17040576
Available online: https://www.mdpi.com/2072-6694/17/4/576

2. “From Embryogenesis to Senescence: The Role of Mammary Gland Physiology in Breast Cancer Risk”
by Jaida C. Lue and Derek C. Radisky
Cancers 2025, 17(4), 787; https://doi.org/10.3390/cancers17050787
Available online: https://www.mdpi.com/2072-6694/17/5/787

3. “Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens”
by Simonetta I. Gaumond, Gabriela E. Beraja, Isabella Kamholtz, Lina M. Ferrari, Rami H. Mahmoud and Joaquin J. Jimenez
Cancers 2025, 17(3), 411; https://doi.org/10.3390/cancers17030411
Available online: https://www.mdpi.com/2072-6694/17/3/411

4. “Early Rectal Cancer: Advances in Diagnosis and Management Strategies”
by Huda Mohammed, Hadeel Mohamed, Nusyba Mohamed, Rajat Sharma and Jayesh Sagar
Cancers 2025, 17(4), 588; https://doi.org/10.3390/cancers17040588
Available online: https://www.mdpi.com/2072-6694/17/4/588

5. “Understanding Cervical Cancer Screening Attendance: Barriers and Facilitators in a Representative Population Survey”
by Bogdan Florin Covaliu, Alina Ioana Forray, Mirela Tomic, Cătălin Vlad, Patriciu Achimaș Cadariu, Carmen Ungurean and Adriana Melnic
Cancers 2025, 17(4), 706; https://doi.org/10.3390/cancers17040706
Available online: https://www.mdpi.com/2072-6694/17/4/706

6. “Racial and Geographic Disparities in Colorectal Cancer Incidence and Associated County-Level Risk Factors in Mississippi, 2003–2020: An Ecological Study”
by Shamim Sarkar, Sasha McKay, Jennie L. Williams and Jaymie R. Meliker
Cancers 2025, 17(2), 192; https://doi.org/10.3390/cancers17020192
Available online: https://www.mdpi.com/2072-6694/17/2/192

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Cancer Causes, Screening and Diagnosis”, which are listed below:

1. “Salivary Gland Cancers in the Era of Molecular Analysis: The Role of Tissue and Liquid Biomarkers”
   by Elisabetta Broseghini, Francesca Carosi, Mirea Berti, Samuele Compagno, Anna Ghelardini, Matteo Fermi, Giulia Querzoli and Daria Maria Filippini
   Cancers 2025, 17(4), 660; https://doi.org/10.3390/cancers17040660
   Available online: https://www.mdpi.com/2072-6694/17/4/660

2. “Fertility Sparing in Endometrial Cancer: Where Are We Now?”
   by Gabriele Centini, Irene Colombi, Ilaria Ianes, Federica Perelli, Alessandro Ginetti, Alberto Cannoni, Nassir Habib, Ramon Rovira Negre, Francesco Giuseppe Martire, Diego Raimondo et al.
   Cancers 2025, 17(1), 112; https://doi.org/10.3390/cancers17010112
   Available online: https://www.mdpi.com/2072-6694/17/1/112

3. “Metabolomic Exploration of Colorectal Cancer Through Amino Acids and Acylcarnitines Profiling of Serum Samples”
   by Lucreția Avram, Dana Crișan, Radu-Cristian Moldovan, Luisa-Gabriela Bogos, Cristina-Adela Iuga, David Andraș, Sorin Crișan, Constantin Bodolea, Andrada Nemeş and Valer Donca
   Cancers 2025, 17(3), 427; https://doi.org/10.3390/cancers17030427
   Available online: https://www.mdpi.com/2072-6694/17/3/427

4. “Liquid Biopsies in the Early Diagnosis, Prognosis, and Tailored Treatment of Colorectal Cancer”
   by Efstathia Liatsou, Ioannis Kollias, Maria Trapali, Diamantis I. Tsilimigras, Maria Gavriatopoulou and Ioannis Ntanasis-Stathopoulos
   Cancers 2025, 17(6), 927; https://doi.org/10.3390/cancers17060927
   Available online: https://www.mdpi.com/2072-6694/17/6/927

5. “The Role of Perirenal Adipose Tissue in Carcinogenesis—From Molecular Mechanism to Therapeutic Perspectives”
   by Adriana Grigoraș and Cornelia Amalinei
   Cancers 2025, 17(7), 1077; https://doi.org/10.3390/cancers17071077
   Available online: https://www.mdpi.com/2072-6694/17/7/1077

6. “Radiotherapy Plus the Neurokinin-1 Receptor Antagonist Aprepitant: A Potent Therapeutic Strategy for the Treatment of Diffuse Intrinsic Pontine Glioma”
   by Miguel Muñoz and Marisa Rosso
   Cancers 2025, 17(3), 520; https://doi.org/10.3390/cancers17030520
   Available online: https://www.mdpi.com/2072-6694/17/3/520

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Transplant Oncology”, which are listed below:

“Evolving Indications for Liver Transplantation for Hepatocellular Carcinoma Following the Milan Criteria”
by Takashi Kokudo and Norihiro Kokudo
Cancers 2025, 17(3), 507; https://doi.org/10.3390/cancers17030507
Available online: https://www.mdpi.com/2072-6694/17/3/507

“The Role of Organoids in Advancing Colorectal Cancer Research: Insights and Future Directions”
by Zahra Heydari, Rex Devasahayam Arokia Balaya, Gobinda Sarkar and Lisa Boardman
Cancers 2025, 17(13), 2129; https://doi.org/10.3390/cancers17132129
Available online: https://www.mdpi.com/2072-6694/17/13/2129

“HepatoPredict Accurately Selects Hepatocellular Carcinoma Patients for Liver Transplantation Regardless of Tumor Heterogeneity”
by Rita Andrade, Judith Perez-Rojas, Sílvia Gomes da Silva, Migla Miskinyte, Margarida C. Quaresma, Laura P. Frazão, Carolina Peixoto, Almudena Cubells, Eva M. Montalvá, António Figueiredo et al.
Cancers 2025, 17(3), 500; https://doi.org/10.3390/cancers17030500
Available online: https://www.mdpi.com/2072-6694/17/3/500

“The Applications of Machine Learning in the Management of Patients Undergoing Stem Cell Transplantation: Are We Ready?”
by Luca Garuffo, Alessandro Leoni, Roberto Gatta and Simona Bernardi
Cancers 2025, 17(3), 395; https://doi.org/10.3390/cancers17030395
Available online: https://www.mdpi.com/2072-6694/17/3/395

“cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid Malignancies”
by Scott D. Rowley, Maher Albitar, Melissa F. Baker, Alaa Ali, Sukhdeep Kaur, Hyung C. Suh, Andre Goy and Michele L. Donato
Cancers 2025, 17(4), 625; https://doi.org/10.3390/cancers17040625
Available online: https://www.mdpi.com/2072-6694/17/4/625

“Post-Transplant Cyclophosphamide-Based Prophylaxis and Its Impact on Infectious Complications and Immune Reconstitution According to Donor Type”
by Beatriz Merchán-Muñoz, María Suárez-Lledó, Luis Gerardo Rodríguez-Lobato, Tommaso Francesco Aiello, Antonio Gallardo-Pizarro, Paola Charry, Joan Cid, Miquel Lozano, Alexandra Pedraza, Alexandra Martínez-Roca et al.
Cancers 2025, 17(7), 1109; https://doi.org/10.3390/cancers17071109
Available online: https://www.mdpi.com/2072-6694/17/7/1109

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Cancer Survivorship and Quality of Life”, which are listed below:

“From Diagnosis to Survivorship: The Role of Social Determinants in Cancer Care”
by Abiha Abdullah, Zeyu Liu and Michele Molinari
Cancers 2025, 17(7), 1067; https://doi.org/10.3390/cancers17071067
Available online: https://www.mdpi.com/2072-6694/17/7/1067

“Psoas Muscle Index as an Independent Predictor of Survival in Patients with Hepatocellular Carcinoma Receiving Systemic Targeted Therapy”
by Kenji Imai, Koji Takai, Masashi Aiba, Shinji Unome, Takao Miwa, Tatsunori Hanai, Hiroyasu Sakai, Yohei Shirakami, Atsushi Suetsugu and Masahito Shimizu
Cancers 2025, 17(2), 209; https://doi.org/10.3390/cancers17020209
Available online: https://www.mdpi.com/2072-6694/17/2/209

“Evaluating Treatment Preferences and the Efficacy of Capsaicin 179 mg Patch vs. Pregabalin in a Randomized Trial for Postsurgical Neuropathic Pain in Breast Cancer: CAPTRANE”
by Denis Dupoiron, Florent Bienfait, Valérie Seegers, François-Xavier Piloquet, Yves-Marie Pluchon, Marie Pechard, Karima Mezaib, Gisèle Chvetzoff, Jésus Diaz, Abesse Ahmeidi et al.
Cancers 2025, 17(2), 313; https://doi.org/10.3390/cancers17020313
Available online: https://www.mdpi.com/2072-6694/17/2/313

“Transfer Learning-Based Integration of Dual Imaging Modalities for Enhanced Classification Accuracy in Confocal Laser Endomicroscopy of Lung Cancer”
by Mircea-Sebastian Șerbănescu, Liliana Streba, Alin Dragoș Demetrian, Andreea-Georgiana Gheorghe, Mădălin Mămuleanu, Daniel-Nicolae Pirici and Costin-Teodor Streba
Cancers 2025, 17(4), 611; https://doi.org/10.3390/cancers17040611
Available online: https://www.mdpi.com/2072-6694/17/4/611

“Evolution of Survival in Patients with Multiple Myeloma over Two Decades: A Real-World Experience from a Medium-Level Hospital”
by Esther Ortega-Vida, Abel Rosado-Rodriguez, Rocio Fe, Victoria Verdugo, Rocio Gavira and Sebastián Garzón
Cancers 2025, 17(5), 793; https://doi.org/10.3390/cancers17050793
Available online: https://www.mdpi.com/2072-6694/17/5/793

“Sleep and Cancer”
by Courtney M. Vaughn and Bradley V. Vaughn.
Cancers 2025, 17(6), 911; https://doi.org/10.3390/cancers17060911
Available online: https://www.mdpi.com/2072-6694/17/6/911

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

World Cervical Cancer Elimination Day is an annual observance aimed at enhancing awareness of cervical cancer prevention and treatment, fostering a deeper recognition of the urgency to eliminate the disease, while also drawing attention to the global health burden it imposes—especially on women’s well-being. This day highlights the pivotal role that collective action plays in advancing cervical cancer screening, vaccination, and access to care, thereby reinforcing the imperative for its elimination. Under the theme “Act Now: Eliminate Cervical Cancer”, calls for bold, united action to build on existing progress and accelerate impact toward the 90-70-90 targets by 2030.

“Progress and Challenges in Canada’s Path Toward the Elimination of Cervical Cancer”
by Samara Perez
Curr. Oncol. 2024, 31(10), 5850-5861; https://doi.org/10.3390/curroncol31100435

“High-Risk HPV Screening Initiative in Kosovo—A Way to Optimize HPV Vaccination for Cervical Cancer”
by Jessica L. Bentz, Rachael E. Barney, Natalia Georgantzoglou, Suzana Manxhuka-Kerliu et al.
Diseases 2024, 12(8), 189; https://doi.org/10.3390/diseases12080189

“Cervical Cancer Genetic Profile through Circulating Tumor DNA: What Can We Learn from Blood?”
by Sevastiani Antonouli, Valentina Di Nisio, Nikoletta Daponte, Athina-Ioanna Daponte and Alexandros Daponte
Biomolecules 2024, 14(7), 825; https://doi.org/10.3390/biom14070825

“An Epidemiological Study of Cervical Cancer Trends among Women with Human Immunodeficiency Virus”
by Arlesia Mathis, Ukamaka D. Smith, Vanessa Crowther, Torhonda Lee and Sandra Suther
Healthcare 2024, 12(12), 1178; https://doi.org/10.3390/healthcare12121178

“Artificial Intelligence and Colposcopy: Automatic Identification of Cervical Squamous Cell Carcinoma Precursors”
by Miguel Mascarenhas, Inês Alencoão, Maria João Carinhas, Miguel Martins, Pedro Cardoso, Francisco Mendes, Joana Fernandes, João Ferreira, Guilherme Macedo and Rosa Zulmira Macedo
J. Clin. Med. 2024, 13(10), 3003; https://doi.org/10.3390/jcm13103003

“Post-Conization HPV Vaccination and Its Impact on Viral Status: A Retrospective Cohort Study in Troms and Finnmark, 2022”
by Marie Rykkelid, Helga Marie Wennberg, Elin Richardsen and Sveinung Wergeland Sørbye
Pathogens 2024, 13(5), 381; https://doi.org/10.3390/pathogens13050381

“Identification and Validation of eRNA as a Prognostic Indicator for Cervical Cancer”
by Lijing Huang, Jingkai Zhang, Zhou Songyang and Yuanyan Xiong
Biology 2024, 13(4), 227; https://doi.org/10.3390/biology13040227

“Cervical Cancer Associated with Pregnancy: Current Challenges and Future Strategies”
by Jennifer Le Guévelou, Lise Selleret, Enora Laas, Fabrice Lecuru and Manon Kissel
Cancers 2024, 16(7), 1341; https://doi.org/10.3390/cancers16071341

“Correlation of the HPV 16 Genotype Persistence in Women Undergoing LEEP for CIN3 with the Risk of CIN2+ Relapses in the First 18 Months of Follow-Up: A Multicenter Retrospective Study”
by Maria Teresa Bruno, Gaetano Valenti, Zaira Ruggeri, Giosuè Giordano Incognito, Paola Coretti, Giuseppe Dario Montana, Marco Marzio Panella and Liliana Mereu
Diagnostics 2024, 14(5), 509; https://doi.org/10.3390/diagnostics14050509

“Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma”
by Jialu Li and Juqun Xi
Genes 2024, 15(1), 121; https://doi.org/10.3390/genes15010121

“Pain in High-Dose-Rate Brachytherapy for Cervical Cancer: A Retrospective Cohort Study”
by Ángel Becerra-Bolaños, Miriam Jiménez-Gil, Mario Federico, Yurena Domínguez-Díaz, Lucía Valencia and Aurelio Rodríguez-Pérez
J. Pers. Med. 2023, 13(8), 1187; https://doi.org/10.3390/jpm13081187

	“Viral Infections, Chronic Inflammation and Carcinogenesis” Guest Editors: Dr. Angioletta Lasagna and Dr. Davide Dalu Submission deadline: 15 February 2026
	“Clinical Management of Cervical Cancer” Guest Editor: Dr. Vanessa Samouëlian Submission deadline: 31 March 2026
	“HPV Vaccine and Cervical Cancer Prevention” Guest Editor: Dr. Andreia Cristina de Melo Submission deadline: 30 April 2026
	“Recent Advances and Strategies for the Management of CIN and HPV Eradication Starategies for the Prevention of Uterine Cervical Cancer” Guest Editor: Dr. Masaru Sakamoto Submission deadline 30 April 2026

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Molecular Cancer Biology”, which are listed below:

1. “Immunotherapy in Prostate Cancer: From a “Cold” Tumor to a “Hot” Prospect”
by Whi-An Kwon and Jae Young Joung
Cancers 2025, 17(7), 1064; https://doi.org/10.3390/cancers17071064
Available online: https://www.mdpi.com/2072-6694/17/7/1064

2. “Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell Malignancies”
by Nawar Maher, Samir Mouhssine, Bassam Francis Matti, Alaa Fadhil Alwan and Gianluca Gaidano
Cancers 2025, 17(5), 907; https://doi.org/10.3390/cancers17050907
Available online: https://www.mdpi.com/2072-6694/17/5/907

3. “Unlocking the Therapeutic Potential of Algae-Derived Compounds in Hematological Malignancies”
by Tamara Vujović, Tina Paradžik, Sanja Babić Brčić and Roberto Piva
Cancers 2025, 17(2), 318; https://doi.org/10.3390/cancers17020318
Available online: https://www.mdpi.com/2072-6694/17/2/318

4. “S-Adenosylmethionine: A Multifaceted Regulator in Cancer Pathogenesis and Therapy”
by David Fernández-Ramos, Fernando Lopitz-Otsoa, Shelly C. Lu and José M. Mato
Cancers 2025, 17(3), 535; https://doi.org/10.3390/cancers17030535
Available online: https://www.mdpi.com/2072-6694/17/3/535

5. “Oncogenic Mutations and the Tumor Microenvironment: Drivers of Non-Small Cell Lung Cancer Progression”
by Achilleas G. Mitrakas, Christos Kakouratos, Ioannis Lamprou, Erasmia Xanthopoulou and Michael I. Koukourakis
Cancers 2025, 17(5), 853; https://doi.org/10.3390/cancers17050853
Available online: https://www.mdpi.com/2072-6694/17/5/853

6. “Calreticulin—From the Endoplasmic Reticulum to the Plasma Membrane—Adventures of a Wandering Protein”
by Gillian C. Okura, Alamelu G. Bharadwaj and David M. Waisman
Cancers 2025, 17(2), 288; https://doi.org/10.3390/cancers17020288
Available online: https://www.mdpi.com/2072-6694/17/2/288

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

Conference: Multiomics and Precision Medicine Joint Conference 2025
Date: 8–9 November 2025
Place: Taipei, Taiwan

We are excited to announce that MDPI will be attending the Multiomics and Precision Medicine Joint Conference 2025 (MOPM 2025) as an exhibitor and proud sponsor of the Special Poster Award Sponsorship, which will recognize six recipients of the MDPI Rising Star Poster Awards.

Now in its seventh edition, MOPM serves as Taiwan’s leading academic platform dedicated to integrative multiomics and precision medicine research. Organized jointly by six major scientific societies, the conference promotes interdisciplinary collaboration across life sciences, medicine, and data science.

This year’s theme, “Big Data and AI Revolution for Next-Generation Precision Medicine”, will highlight cutting-edge applications of artificial intelligence and big data in biotechnology and healthcare. The program will feature plenary talks from international experts, poster presentations, industry showcases, and exhibitions of the latest research and technologies — fostering dialogue and collaboration among scholars and professionals across disciplines.

The following MDPI journals will be represented:

• Proteomes;
• Sclerosis;
• Metabolites;
• Biomolecules;
• Cancers;
• Cells;
• Journal of Clinical Medicine (JCM);
• Journal of Personalized Medicine (JPM);
• Pharmaceuticals.

If you will be attending this conference, our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.mopmtaiwan.com.

We are delighted to share a collection of highly viewed papers in the “Cancer Therapy” Section that were published in Cancers (ISSN: 2072-6694) in the first half of 2025. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:

The list of relevant papers can be seen below:

“Recent Anti-KRAS^G12D Therapies: A “Possible Impossibility” for Pancreatic Ductal Adenocarcinoma”
by Navid Sobhani, Matteo Pittacolo, Alberto D’Angelo and Giovanni Marchegiani
Cancers 2025, 17(4), 704; https://doi.org/10.3390/cancers17040704
Available online: https://www.mdpi.com/2072-6694/17/4/704

“Advancing Cancer Treatment: A Review of Immune Checkpoint Inhibitors and Combination Strategies”
by Valencia Mc Neil and Seung Won Lee
Cancers 2025, 17(9), 1408; https://doi.org/10.3390/cancers17091408
Available online: https://www.mdpi.com/2072-6694/17/9/1408

“Ancestry-Specific DNA Damage Repair Gene Mutations and Prostate Cancer”
by Talaibek Borbiev, Kevin Babcock, Kayleigh Sinopole, Gregory T. Chesnut and Gyorgy Petrovics
Cancers 2025, 17(4), 682; https://doi.org/10.3390/cancers17040682
Available online: https://www.mdpi.com/2072-6694/17/4/682

“Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition”
by Ewa Błaszczak, Paulina Miziak, Adrian Odrzywolski, Marzena Baran, Ewelina Gumbarewicz and Andrzej Stepulak
Cancers 2025, 17(2), 228; https://doi.org/10.3390/cancers17020228
Available online: https://www.mdpi.com/2072-6694/17/2/228

“Optimizing Osimertinib for NSCLC: Targeting Resistance and Exploring Combination Therapeutics”
by Yan-You Liao, Chia-Luen Tsai and Hsiang-Po Huang
Cancers 2025, 17(3), 459; https://doi.org/10.3390/cancers17030459
Available online: https://www.mdpi.com/2072-6694/17/3/459

“Comprehensive Review of Early and Late Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatments for Hematologic Malignancies”
by Ayrton Bangolo, Behzad Amoozgar, Charlene Mansour, Lili Zhang, Sarvarinder Gill, Andrew Ip and Christina Cho
Cancers 2025, 17(2), 282; https://doi.org/10.3390/cancers17020282
Available online: https://www.mdpi.com/2072-6694/17/2/282

Special Issues:

You can view and submit relevant papers to Cancers via the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office